Acute Dental Pain Management Guideline (2022)

Public comments are being sought for an upcoming clinical practice guideline on the management of acute dental pain.

We want to hear from you!

The ADA Science & Research Institute, the University of Pittsburgh, and the University of Pennsylvania are writing a clinical practice guideline for the management of acute pain in dentistry, including the use of non-steroidal anti-inflammatory drugs (NSAIDs) and opioids. To help inform the guideline's development, we are currently seeking comments from the public on the guideline’s recommendations and good practice statements.

To submit comments, please use the form below. Comments may be general or specific. If offering specific feedback, please note the exact part of the guideline's recommendations and good practice statements that you are referring to and provide any references to support your comments.

All submitted feedback will be reviewed by the guideline's authors. The deadline to submit comments is December 5.

Frequently asked questions

Who is producing this guideline?

The clinical practice guideline on the management of acute dental pain is being written by an expert panel and a team of methodologists at the ADA Science & Research Institute, University of Pittsburgh, and the University of Pennsylvania.

This project is supported by the Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $1.5 million with 100 percent funded by FDA/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by FDA/HHS, or the U.S. Government.

How were these recommendations and good practice statements developed?

The upcoming guideline for the management of acute dental pain (surgical and non-surgical) was informed by a systematic review of the best available scientific evidence. An expert panel chaired by Paul Moore, DMD, PhD, a professor of pharmacology at the University of Pittsburgh School of Dental Medicine, then used this review to draft the recommendations and good practice statements presented here.

What are the differences between recommendations and good practice statements?
There is a reason why some of the statements available through the blue button above are considered recommendations while others are considered good practice statements. Recommendations are developed via a comprehensive search of the evidence and further include a formal rating of the quality of the evidence. Good practice statements, however, provide guidance that is supposed to be supported by an overwhelming amount of indirect evidence. Attempts to summarize and assess the quality of this evidence would have been a poor use of the expert panel’s time.
Where will these recommendations and good practice statements ultimately be published?
These recommendations and good practice statements will appear in the guideline for the management of acute pain in dentistry. The guideline manuscript will be submitted in 2022 to a peer-reviewed journal for publication. To be added to the guideline's email list and receive updates regarding publication, please email SRI@ADA.org.